1. 急性 ST 段抬高型心肌梗死合并射血分数保留的心力衰竭患者 SII, FAR, CAR 与 PCI 术中无复流的关系.
- Author
-
梁权满, 宋天宇, 容 皓, 陈图刚, and 陈 灿
- Abstract
Objective: To investigate the relationship between systemic immune inflammatory index (SII), fibrinogen/albumin ratio (FAR), C-reactive protein/albumin ratio (CAR) and no-reflow during percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction (STEMI) and heart failure with preserved ejection fraction (HFpEF). Methods: 155 patients with STE- MI and HFpEF who underwent direct PCI in our hospital from May 2020 to May 2023 were prospectively selected, patients were divided into no-reflow group (n=35) and normal-reflow group (n=120) according to the blood flow during PCI. SII, FAR and CAR were calculated. The factors of no-reflow during PCI in patients with STEMI and HFpEF were analyzed by multivariate Logistic regression model, the predictive value of SII, FAR and CAR for no-reflow during PCI in patients with STEMI and HFpEF were analyzed by drawn receiver operating characteristic (ROC) curve. Results: The incidence of no-reflow during PCI in 155 patients with STEMI and HFpEF was 22.58% (35/155). Compared with normal-reflow group, SII, FAR and CAR increased in no-reflow group (P<0.05). The independent risk factors for no-reflow during PCI in patients with STEMI and HFpEF were increased age and increased SII, FAR and CAR (P<0.05). The area under the curve of SII, FAR, CAR alone and SII, FAR, CAR combined to predict no-reflow during PCI in patients with STEMI and HFpEF was 0.811, 0.800, 0.788, 0.940 respectively. Conclusion: The increase of SII, FAR and CAR in patients with STEMI and HFpEF is an independent risk factor for no-reflow during PCI, the combination of SII, FAR and CAR has a high predictive value for no-reflow during PCI in patients with STEMI and HFpEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF